01 Development of Long-Term Continuous ECG Monitoring Patches The need to detect intermittent and asymptomatic arrhythmias is increasing the use of ECG patches that can record cardiac activity for several days rather than only the traditional 24-hour Holter period. A prospective study of 158 patients found that a 14-day ECG patch detected arrhythmias in 59.5% of patients compared with 19.0% with 24-hour Holter monitoring. This longer monitoring capability can improve the identification of sporadic rhythm abnormalities and support more effective ambulatory cardiac assessment.
02 Adoption of Multi-Lead and High-Resolution ECG Patches The need for richer cardiac electrical information is encouraging the development of wearable patches with multiple leads and higher-resolution signal acquisition. Recent research has demonstrated wearable 12-lead ECG systems capable of synchronized multichannel recording with a 500 Hz sampling frequency and high-resolution analog front-end technology. These advances can provide more detailed ECG signals and expand the potential use of wearable patches for rhythm and morphological assessment beyond basic single-lead monitoring.
01 Cardiac Follow-Up and Symptom Evaluation Drive Market The need for cardiac follow-up after treatment creates demand for ambulatory monitoring devices that can capture heart rhythm information outside clinical settings. The American Heart Association notes that ambulatory ECG monitoring can help assess whether treatment for an arrhythmia is working and whether additional treatment may be needed. For example, a patient after an arrhythmia procedure may use a Holter monitor to record ECG activity during normal daily activities as part of clinical follow-up. This follow-up requirement supports device utilization and creates continued demand for Holter monitors and related diagnostic services.The occurrence of unexplained fainting and palpitations creates a need for objective rhythm information that may not be captured during a short clinical ECG. The American College of Cardiology states that ambulatory ECG monitoring is useful for correlating symptoms such as syncope and palpitations with cardiac rhythm. For example, a patient with occasional dizziness or unexplained palpitations can wear an ambulatory monitor to capture ECG activity during symptomatic episodes. This diagnostic requirement supports the use of ECG patches and Holter monitors across outpatient cardiology services.
01 Data Management and Connectivity Challenges Restrain Market Expansion Data management and interpretation challenges can arise from the large volume of ECG recordings generated during prolonged monitoring and the need to distinguish clinically relevant arrhythmias from noise and artifacts. The american heart association notes that ambulatory ECG monitoring can generate substantial amounts of data that require analysis by trained professionals, particularly for longer monitoring periods. These data-processing and interpretation requirements can increase clinical workload and limit the adoption of ECG patches and Holter monitors.Connectivity and data transmission issues can occur when ECG patches and connected Holter monitors rely on wireless networks or mobile connectivity to transmit recordings for remote analysis. The U.S. FDA recognizes wireless communication failures and connectivity problems as potential risks for medical devices that depend on wireless technology. Transmission interruptions can cause delays or incomplete data transfer, reducing monitoring reliability and slowing the adoption of connected ECG monitoring devices.
01 Cardiology Partnerships and Sports & Occupational ECG Monitoring Offers Growth Opportunities ECG patch and Holter monitor manufacturers can partner with hospitals and cardiology clinics for device supply, remote monitoring, and diagnostic services. iRhythm’s Zio service integrates with EHR systems and provides end-to-end monitoring, while its platform has generated more than 10 million patient reports, creating revenue through device use and monitoring services.Sports organizations, occupational health providers, employers, and medical centers can use ECG monitoring for cardiac screening and activity-related assessments. iRhythm’s Zio monitor supports routine activities including exercise and provides continuous ECG recording for up to 14 days, creating opportunities for bulk device programs and recurring monitoring services.
01 Battery Constraints and Consumable Requirements Hinders Growth Long-term monitoring devices must maintain reliable operation throughout the prescribed monitoring period without frequent charging or replacement. Ambulatory ECG monitors can be prescribed for periods ranging from 24 hours to several weeks, increasing the importance of dependable device operation throughout monitoring. Battery limitations or device-maintenance requirements can interrupt monitoring, affect user experience, and make longer-duration solutions more difficult to scale.Many ECG patches are designed for single-use monitoring, creating recurring requirements for electrodes, patches, batteries, and other consumables. Disposable ECG electrodes and ambulatory ECG monitoring components are commonly used for individual patient monitoring, creating recurring consumable requirements across monitoring workflows. Higher recurring material, inventory, and disposal requirements can increase the total cost of monitoring and slow adoption among cost-sensitive healthcare facilities.
March 2026 iRhythm Technologies expanded its Zio® cardiac monitoring portfolio with advanced ECG patch technologies and AI-powered analysis solutions designed to improve arrhythmia detection and remote cardiac monitoring.
January 2026 Philips expanded its ambulatory cardiac monitoring solutions with enhanced ECG patch and Holter monitoring technologies, supporting remote patient monitoring and improved cardiac care delivery.
October 2025 BioTelemetry (Philips company) expanded its cardiac monitoring services with advanced Holter monitoring platforms and digital analytics solutions designed to support continuous heart rhythm assessment.
August 2025 AliveCor expanded its ECG monitoring portfolio with advanced wearable cardiac devices and AI-based ECG analysis solutions, enabling improved detection of irregular heart rhythms.